Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.32
-0.06 (-0.64%)
Apr 9, 2026, 12:01 PM EDT - Market open
Biohaven Employees
Biohaven had 274 employees as of December 31, 2025. The number of employees increased by 18 or 7.03% compared to the previous year.
Employees
274
Change (1Y)
18
Growth (1Y)
7.03%
Revenue / Employee
n/a
Profits / Employee
-$2,696,431
Market Cap
1.40B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 274 | 18 | 7.03% |
| Dec 31, 2024 | 256 | 17 | 7.11% |
| Dec 31, 2023 | 239 | 37 | 18.32% |
| Dec 31, 2022 | 202 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| Immatics | 711 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Monte Rosa Therapeutics | 150 |
| Maze Therapeutics | 141 |
| Olema Pharmaceuticals | 131 |
BHVN News
- 21 days ago - Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment - PRNewsWire
- 5 weeks ago - Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 3 months ago - Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - PRNewsWire
- 3 months ago - US Stocks Mixed; Biohaven Shares Fall - Benzinga
- 3 months ago - Biohaven Misses The Mark In Depression Trial, Stock Falls - Benzinga
- 3 months ago - Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus - Benzinga
- 3 months ago - Biohaven's depression drug fails mid-stage trial, shares fall - Reuters